Marine Le Pen's far-right National Rally party's surprising EU election success prompts a snap election in France, causing concern for the rest of the EU. Bloomberg discusses the rise of far-right movements in Europe, their potential impact on US relations, and the implications for the left in pivotal election year.

Bloomberg Businessweek editor Matt Campbell discusses the dark side of Indonesia's booming nickel industry for EV batteries, highlighting fatal accidents and unethical practices. The investigation reveals the global impact on the car industry's green revolution and the challenges faced by automakers in ethical nickel sourcing.

Bloomberg data reporter Jinshan Hong joins host Sarah Holder to investigate the rise in global sickness post-pandemic, exploring potential causes like weakened immunity and decreased disease exposure during quarantine. They discuss the impact of lockdowns, anti-vaccine movements, and climate change on public health, offering insights on staying healthy in these challenging times.

Bloomberg legal reporter Patricia Hurtado and Congress editor Megan Scully discuss the scandalous trial of Senator Bob Menendez, including bribery allegations, hidden gold bars, and a secret FBI recording. They explore how the case could impact the Democratic Party's image and Senate control amidst an uphill battle.

Bloomberg's Managing Editor for US economic policy Kate Davidson and Bloomberg Opinion columnist Mohamed El-Erian discuss the Federal Reserve's inflation target of 2%, the risks of being wrong about it, and who could be most impacted. They explore the challenges in reaching the target, credibility issues during the pandemic, transitory inflation risks, global economic shifts towards protectionism, and strategies to control inflation and restore price stability.

Bloomberg investing reporter David Ramli sheds light on the secretive family office industry, discussing how scammers are targeting the ultra-rich in Asia. Medway Investment board director Eric SayWei Neo shares insights on detecting imposters in the financial sector.

A Bloomberg investigation uncovers tainted drugs made in unsanitary factories used by big pharmacy chains. CVS had double the recalls of competitors due to loopholes. The podcast discusses the challenges in identifying manufacturers, FDA inspection reports, and the impact of consumer decisions on drug quality.

The podcast discusses Ukraine's reliance on old battlefield technology from the US, the shortage of essential equipment and supplies in Ukraine's defense, the challenges faced by Ukrainian soldiers, and the varying opinions in the US on supporting Ukraine's defense efforts.

Bloomberg's White House correspondent and Israel's bureau chief discuss President Biden's push for a cease-fire in Israel. They analyze the hurdles facing the proposal and the next steps for Biden and Netanyahu amidst the escalating violence in Gaza.

Sam Altman, CEO of OpenAI, is discussed with a focus on trust, power dynamics in AI development, and his role in tech startups. The podcast explores Altman's reputation, family influences, and the challenges faced by OpenAI. The rise, fall, and reinstatement of Altman as CEO, his pivotal role in AI technology, adolescence, early tech ventures, and presidency at Y Combinator are also highlighted. Additionally, Elon Musk's concerns about AI advancement and the birth and challenges of OpenAI are explored.